On April 21, Winsan(Chengdu) Medical Science And Technology Company Limited(600767) issued a suggestive announcement on planning major asset restructuring and signing the equity acquisition intention agreement. According to the announcement, Winsan(Chengdu) Medical Science And Technology Company Limited(600767) signed the agreement of intention to acquire shares with Shenzhen Glenfield Enterprise Management Co., Ltd., Shenzhen Glenfield oral Management Co., Ltd., Zhang huitu, Qin Youbing, Peng Zhenhua and Shenzhen Glenfield oral Group Co., Ltd. (hereinafter referred to as “Glenfield oral”) to acquire 52% of the equity of Glenfield oral by paying cash, so as to build a new business in the medical service sector of the company, Form new profit growth points and enhance the company’s core competitiveness.
After preliminary research and calculation, this transaction is expected to constitute a major asset reorganization stipulated in the administrative measures for major asset reorganization of listed companies. According to the principle of “prudent suspension and phased disclosure”, the trading of the company’s shares will not be suspended. The company will timely perform the obligation of information disclosure in stages according to the provisions of the articles of association and relevant laws and regulations and the progress of relevant matters.
It is understood that Glenfield oral is headquartered in Shenzhen. It is a large oral chain hospital integrating medical treatment, teaching and scientific research. It has 16 oral medical service institutions in Shenzhen. Glenfield stomatology took the lead in proposing the treatment service mode of “one city, multiple hospitals and technology sharing”. Its main business includes dental implantation, orthodontics, dental restoration, periodontal treatment and children’s dentistry. Its business has covered the main urban areas of Shenzhen. It has a strong brand advantage in Shenzhen and provides customers with high-quality personalized oral medical services.
Winsan(Chengdu) Medical Science And Technology Company Limited(600767) said that after the completion of this transaction, Glenfield oral will become the holding subsidiary of the company, and the company will quickly enter the oral medicine industry and obtain the existing high-quality team and store resources of Glenfield oral. Glenfield dental’s oral medical service industry has a good prospect and has a broad market space. This transaction is in line with the company’s strategic development direction, helps to create new business in the company’s medical service sector, and lays a good foundation for the company’s further development in the field of medical health. At the same time, it will help the company form a new profit growth point and further improve its comprehensive competitiveness.
